Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Diabetes & Metabolic Disorders
Published in: Journal of Diabetes & Metabolic Disorders 2/2020

01-12-2020 | Mood Disorders | Research article

Depression in Barbadian adults with type 2 diabetes

Authors: Allison A. DaSantos, Carlisle Goddard, Dalip Ragoobirsingh

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2020

Login to get access

Abstract

Purpose

The aim of this study was to explore the frequency and distribution of depression in Barbadian adults with type 2 diabetes.

Methods

Adults aged 20–80 years with type 2 diabetes, completed a cross-sectional survey comprised of, a profile section, and the standardized questionnaire; the Patient Health Questionnaire (PHQ-9). Additionally, biological (HbA1c and blood pressure) measurements were collected.

Results

For the 509 participants, 65.4%, 1.4%, 22% and 8% showed minimal, moderately severe to severe; mild and moderate depression respectively. Female participants ranked higher in depression than males. Persons who reported having never been married were identified as having the greatest prevalence of mild and severe depression. There was a small positive correlation between glycemic control and depression.

Conclusions

The results suggest that the presence of this affective disorder may be under-recognized in Barbadian patients with type 2 diabetes mellitus. Management protocol could incorporate the screening for depression.
Literature
1.
2.
La S, Rj W, Te F. Chronic diseases–facing a public health challenge. West Indian Med J. 2001;50(Suppl 4):27–31.
3.
Geneau R, Stuckler D, Stachenko S, McKee M, Ebrahim S, Basu S, et al. Raising the priority of preventing chronic diseases: a political process. Lancet. 2010;376:1689–98. CrossRef
4.
5.
6.
Adams OP, Carter AO. Knowledge, attitudes, practices, and barriers reported by patients receiving diabetes and hypertension primary health care in Barbados: a focus group study. BMC Fam Pract. 2011;12:135.CrossRef
7.
8.
Fisher L, Skaff MM, Mullan JT, Arean P, Glasgow R, Masharani U. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes. Diabet Med J Br Diabet Assoc. 2008;25:1096–101.CrossRef
9.
Ott A, Stolk RP, van Harskamp F, Pols HAP, Hofman A, Breteler MMB. Diabetes mellitus and the risk of dementia. The Rotterdam study. Neurology. 1999;53:1937–7.CrossRef
10.
Llorente MD, Urrutia V, Diabetes. Psychiatric Disorders, and the Metabolic Effects of Antipsychotic Medications. Clin Diabetes. 2006;24:18–24.CrossRef
11.
Egede LE, Ellis C. Diabetes and depression: Global perspectives. Diabetes Res Clin Pract. 2010;87:302–12.CrossRef
12.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The Prevalence of Comorbid Depression in Adults With Diabetes A meta-analysis. Diabetes Care. 2001;24:1069–78.CrossRef
13.
Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care. 2003;26:2822–8.
14.
Peyrot M, Rubin RR. Levels and Risks of Depression and Anxiety Symptomatology Among Diabetic Adults. Diabetes Care. 1997;20:585–90.CrossRef
15.
Karlson B, Agardh CD. Burden of illness, metabolic control, and complications in relation to depressive symptoms in IDDM patients. Diabet Med J Br Diabet Assoc. 1997;14:1066–72.CrossRef
16.
Lin EHB, Von Korff M. Mental disorders among persons with diabetes—Results from the world mental health surveys. J Psychosom Res. 2008;65:571–80. CrossRef
17.
Monroe CE, Affuso O, Martin MY, Aung M, Crossman L, Jolly PE. Correlates of symptoms of depression and anxiety among clinic outpatients in Western Jamaica. West Indian Med J. 2013;62:533–42.CrossRef
18.
Gibson RC, Neita SM, Abel WD, James K, Eldemire-Shearer D. Sociodemographic factors associated with depressive symptoms among elderly persons from two communities in Kingston, Jamaica. West Indian Med J. 2013;62:615–9.CrossRef
19.
Martin JS, Neita SM, Gibson RC. Depression among cardiovascular disease patients on a consultation-liaison service at a General Hospital in Jamaica. West Indian Med J. 2012;61:499–503.CrossRef
20.
Hickling FW. The epidemiology of schizophrenia and other common mental health disorders in the English-speaking Caribbean. Rev Panam Salud Pública. 2005;18:256–62.CrossRef
21.
Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32:509–15.CrossRef
22.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum; 1988.
23.
Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med J Br Diabet Assoc. 2006;23:1165–73.CrossRef
24.
Asghar S, Hussain A, Ali SMK, Khan AKA, Magnusson A. Prevalence of depression and diabetes: a population-based study from rural Bangladesh. Diabet Med J Br Diabet Assoc. 2007;24:872–7.CrossRef
25.
Joseph N, Unnikrishnan B, Raghavendra Babu Y, Kotian Ms, Nelliyanil M. Proportion of depression and its determinants among type 2 diabetes mellitus patients in various tertiary care hospitals in Mangalore city of South India. Indian J Endocrinol Metab. 2013;17:681.CrossRef
26.
Frederick FT, Maharajh HD. Prevalencia de la depresión en pacientes con diabetes tipo 2 en Trinidad y Tobago. West Indian Med J. 2013;62:628–31.PubMed
27.
Detzer MJ, Wendt SJ, Solomon LJ, Dorsch E, Geller BM, Friedman J, et al. Barriers to condom use among women attending planned parenthood clinics. Women Health. 1995;23:91–102.CrossRef
28.
Scott KM, Wells JE, Angermeyer M, Brugha TS, Bromet E, Demyttenaere K, et al. Gender and the relationship between marital status and first onset of mood, anxiety and substance use disorders. Psychol Med. 2010;40:1495–505.CrossRef
29.
Eren I, Erdi O, Ozcankaya R. [Relationship between blood glucose control and psychiatric disorders in type II diabetic patients]. Türk Psikiyatri Derg Turk J Psychiatry. 2003;14:184–91.
30.
Zuberi SI, Syed EU, Bhatti JA. Association of depression with treatment outcomes in Type 2 Diabetes Mellitus: A cross-sectional study from Karachi, Pakistan. BMC Psychiatry. 2011;11:27.CrossRef
31.
32.
Bolton P, Bass J, Neugebauer R. Group interpersonal psychotherapy for depression in rural uganda: A randomized controlled trial. JAMA. 2003;289:3117–24.CrossRef
33.
Araya R, Flynn T, Rojas G, Fritsch R, Simon G. Cost-effectiveness of a primary care treatment program for depression in low-income women in Santiago, Chile. Am J Psychiatry. 2006;163:1379–87.CrossRef
34.
Patel V, Weiss HA, Chowdhary N, Naik S, Pednekar S, Chatterjee S, et al. Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial. Lancet. 2010;376:2086–95. CrossRef
35.
Dziemidok P, Makara-Studzińska M, Jarosz MJ. Diabetes and depression: a combination of civilization and life-style diseases is more than simple problem adding - literature review. Ann Agric Environ Med AAEM. 2011;18:318–22.PubMed
Metadata
Title
Depression in Barbadian adults with type 2 diabetes
Authors
Allison A. DaSantos
Carlisle Goddard
Dalip Ragoobirsingh
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00677-z

Other articles of this Issue 2/2020

Journal of Diabetes & Metabolic Disorders 2/2020 Go to the issue

Research article

Short term therapeutic efficacy of camel milk Vis-À-Vis buffalo milk in Alloxan® induced diabetic rabbits

Review article

Hostile personality as a risk factor for hyperglycemia and obesity in adult populations: a systematic review

Research article

Adaptation and validity assessment of a diet quality index for patients with type 2 diabetes

Review article

The effects of omega-3 fatty acids supplementation on metabolic status in pregnant women: a systematic review and meta-analysis of randomized controlled trials

Research article

Factors associated with the poor outcomes in diabetic patients with COVID-19

Research article

Low advanced Glycation end product diet improves the central obesity, insulin resistance and inflammatory profiles in Iranian patients with metabolic syndrome: a randomized clinical trial
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits